NCT04452747

Brief Summary

Labour induction is an obstetrical procedure, which artificially starts the process of cervix dilation, in order to induce labour. Several methods of labour induction exist : mechanical ones (using dilatation balloons) or pharmacological ones (using prostaglandins or oxytocin). This trial aims to compare, in case of non-favourable cervix, the strategy of labour induction using the Propess® method first (Dino-first) versus the strategy beginning with the use of a dilatation balloon (Ballon-first), with respect of the usual practice and the current guidelines.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
450

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Nov 2020

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 23, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 30, 2020

Completed
5 months until next milestone

Study Start

First participant enrolled

November 16, 2020

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 2, 2022

Completed
5 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2023

Completed
Last Updated

May 15, 2023

Status Verified

May 1, 2023

Enrollment Period

1.9 years

First QC Date

June 23, 2020

Last Update Submit

May 12, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Rate of vaginal deliveries

    Rate of vaginal deliveries (both spontaneous or instrumentally assisted)

    On the day of the delivery

Secondary Outcomes (23)

  • Rate of spontaneous vaginal deliveries

    On the day of the delivery

  • Rate of instrumentally assisted vaginal deliveries, including the reason for the assistance

    On the day of the delivery

  • Rate of C-section including the reason for the C-section

    On the day of the delivery

  • Timeframe between the beginning of the induction and the beginning of the labour

    On the day of the delivery

  • Cumulated rate of spontaneous vaginal deliveries

    at 12 hours, 24 hours and 48 hours

  • +18 more secondary outcomes

Study Arms (2)

Dino-first

ACTIVE COMPARATOR

Labour will be induced by the use of the vaginal Dinoprostone system (Propess®) first.

Procedure: Vaginal Dinoprostone system (Propess®)

Balloon-first

ACTIVE COMPARATOR

Labour will be induced by the use of a cervix dilatation balloon first.

Procedure: Dilatation balloon

Interventions

Labour will be induced using the vaginal Dinoprostone system (Propess®) as a first strategy

Dino-first

Labour will be induced using a cervix dilatation balloon as a first strategy

Balloon-first

Eligibility Criteria

Age18 Years+
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Women with singleton pregnancy
  • Fetus with cephalic presentation
  • Intact membranes between 37 and 42 weeks of amenorrhea
  • Medical indication for labour induction according to the "Haute Autorité de Santé" (HAS) guidelines
  • Unfavourable cervix (Bishop scoring \< 7)
  • Age \> 18 years-old
  • Person affiliated to a healthcare system
  • Good understanding of the French language

You may not qualify if:

  • Previous C-section or uterine incision
  • Placenta previa
  • Metrorrhagia of unknown origin
  • Lethal foetal abnormality
  • Hyperreactivity to one of the molecules used for the induction (dinoprostone or oxytocin) or to latex
  • Subject participants to another biomedical research
  • Subject under legal guardianship or curatorship

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Montpellier University Hospital

Montpellier, 34295, France

Location

Nimes University Hospital

Nîmes, 30029, France

Location

Study Officials

  • Florent FUCHS, MD PhD

    UH of Montpellier

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 23, 2020

First Posted

June 30, 2020

Study Start

November 16, 2020

Primary Completion

October 2, 2022

Study Completion

March 1, 2023

Last Updated

May 15, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will not share

Locations